ClinicalTrials.gov record
Enrolling by invitation No phase listed Observational

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy

ClinicalTrials.gov ID: NCT05296447

Public ClinicalTrials.gov record NCT05296447. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-term Follow-Up Study to Evaluate the Safety and Efficacy of Suprachoroidal Administration of RGX-314 for Diabetic Retinopathy Without Center Involved-Diabetic Macular Edema

Study identification

NCT ID
NCT05296447
Recruitment status
Enrolling by invitation
Study type
Observational
Phase
Not listed
Lead sponsor
AbbVie
Industry
Enrollment
100 participants

Conditions and interventions

Interventions

  • No Intervention Other

Other

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 3, 2022
Primary completion
Apr 30, 2028
Completion
Apr 30, 2028
Last update posted
Jun 17, 2025

2022 – 2028

United States locations

U.S. sites
19
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Retinal Research Institute, LLC Phoenix Arizona 85014
California Retina Consultants Bakersfield California 93309
Retina-Vitreous Associates Medical Group Beverly Hills California 90211
American Institute of Research Los Angeles California 90017
Northern California Retina Vitreous Associates Medical Group Inc Mountain View California 94040
California Eye Specialists Medical Group, Inc Pasadena California 91107
Retina Consultants San Diego Poway California 92064
California Retina Consultants CRC Santa Barbara California 93103
University Retina and Macula Associates, PC Oak Forest Illinois 60452
Cumberland Valley Retina Consultants Hagerstown Maryland 21740
Ophthalmic Consultants of Boston Boston Massachusetts 02114
Sierra eye Associates Reno Nevada 89502
New Jersey Retina Teaneck New Jersey 07666
Vision Research Center Eye Associates of New Mexico Albuquerque New Mexico 87109
Duke University Durham North Carolina 27705
Retinovitreous Associates, LTD Philadelphia Pennsylvania 19107
Charles Retina Institute, P.C Germantown Tennessee 38138
Austin Clinical Research Austin Texas 78750
Retina Consultants of Texas The Woodlands Texas 77384

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05296447, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 17, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05296447 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →